UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024879
Receipt number R000028631
Scientific Title The effect of gastric secretion on lower intestinal microflora.
Date of disclosure of the study information 2016/11/17
Last modified on 2016/11/17 16:54:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of gastric secretion on lower intestinal microflora.

Acronym

The effect of gastric secretion on lower intestinal microflora.

Scientific Title

The effect of gastric secretion on lower intestinal microflora.

Scientific Title:Acronym

The effect of gastric secretion on lower intestinal microflora.

Region

Japan


Condition

Condition

healthy stomoach, atrophic gastritis

Classification by specialty

Medicine in general Gastroenterology Hepato-biliary-pancreatic medicine
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigete the Improvement effect of Japanese apricot on lower intestinal microflora and serum cytokine.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

lower intestinal microflora , serum cytokine, serum triglyceride and serum cholesterol value

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Healthy stomoach, atrophic gastritis

Key exclusion criteria

a person with a history of the gastrectomyand Hp erradication, a person who takes PPI and H2 receptor blocker

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takao Maekita

Organization

School of Medicine, Wakayama Medical University

Division name

Department of Gastroenterology

Zip code


Address

811-1 Kimiidera, Wakayama, Wakayama 641-0012, Japan

TEL

073-447-2300

Email

maekita@wakayama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takao Maekita

Organization

School of Medicine, Wakayama Medical University

Division name

Department of Gastroenterology

Zip code


Address

811-1 Kimiidera, Wakayama, Wakayama 641-0012, Japan

TEL

073-447-2300

Homepage URL


Email

maekita@wakayama-med.ac.jp


Sponsor or person

Institute

School of Medicine, Wakayama Medical University

Institute

Department

Personal name



Funding Source

Organization

School of Medicine, Wakayama Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2010 Year 08 Month 24 Day

Date of IRB


Anticipated trial start date

2010 Year 08 Month 24 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Participants included individuals who receive specific medical check-ups by the local community health service and have a medical examination in Wakayama Medical University Hospital. Helicobacter Pyloti-related gastritis are examined using a serum PG test and anti-Helicobacter IgG antibody.Subjects are divided into Four groups according to progress of atrophy.Investigate lower intestinal microflora in four groups.


Management information

Registered date

2016 Year 11 Month 17 Day

Last modified on

2016 Year 11 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028631


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name